Lumen Bioscience: Spirulina-based platform enables rapid, low-cost development of oral biologics 07-Apr-2022 By Jane Byrne Spirulina has been converted into a biomanufacturing platform that offers a way to rapidly produce mass quantities of biologic drugs for common diseases that currently lack effective treatments, say US developers.
